20 May 2025
Caledonia Investments plc Final results for the year ended 31 March 2025 Financial highlights Year ended 31 March 2025 Year ended 31 March…
Acquisition of EsoBiotec completed AstraZeneca today announced the successful completion of the acquisition of EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated…
LONDONMETRIC PROPERTY PLC (“LondonMetric” or the “Group” or the “Company”) FULL YEAR RESULTS FOR THE YEAR ENDED 31 MARCH 2025 Our activity has driven…
19 May 2025
HARWORTH GROUP PLC (‘Harworth’ or the ‘Group’ or the ‘Company’) AGM Statement Significant progress across major sites and submission of Northern Gateway planning application…
JPMORGAN INDIAN INVESTMENT TRUST PLC (the ‘Company’) Strategic Update: Enhanced discount control mechanisms, the introduction of a dividend distribution policy and investment management fee…
Diageo issues fiscal 25 Q3 trading statement Strong Q3 organic net sales growth. On track for full year with sequential improvement in H2 Debra…
Blenrep (belantamab mafodotin) combinations approved in Japan for treatment of relapsed/refractory multiple myeloma GSK plc (LSE/NYSE: GSK) today announced the approval of Blenrep combinations by Japanfs Ministry…
16 May 2025
LAND SECURITIES GROUP PLC (“Landsec”) Results for the year ended 31 March 2025 Strong operational results set to drive continued growth Mark Allan, Chief…